Photys

Life Sciences

back to list

[Details]

Stage

Founded

Region

Fund

website

twitter

[overview]

Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms.

[links]

Announcing Our Investment in Photys Therapeutics

We’re pleased to announce 8VC’s participation in the $75 million Series A for Photys Therapeutics, led by MPM Capital and joined by Omega Funds, Longwood, Arkin Bio, Mass General Brigham Ventures, MRL Ventures Fund, Eli Lilly and Company, and Heritage Medical Systems.

No related items found.

view all resources

[featured articles]